
Mar 15, 2025, 09:06
Myeloma Paper of the Day, March 15th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of patient-reported outcomes and survival and adverse events in daratumumab-treated myeloma finds (surprisingly!) low physical function patients experienced greater OS and PFS benefit.”
Authors: Ahmad Abuhelwa, Sara Almansour, Ethan Basch, Humaid Al-Shamsi, Ziad Abuhelwa, Yasser Bustanji, Mohammad Semreen, Zelal Kharaba, Salma Ali, Rawan Mohamed, Ganessan Kichenadasse, Ross McKinnon, Michael Sorich, Karem Alzoubi, Ashley Hopkins.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 15, 2025, 09:06
Mar 15, 2025, 08:48
Mar 15, 2025, 08:27
Mar 15, 2025, 08:18
Mar 15, 2025, 07:47